GlaxoSmithKline Financial Overview
GlaxoSmithKline's market cap is currently £72.84B. The company's EPS TTM is p0.55; its P/E ratio is 13.35; and it has a dividend yield of 3.29%. GlaxoSmithKline is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is p0.24. See an overview of income statement, balance sheet, and cash flow financials.
